Bioreactors Market by Mechanism (Airlift Bioreactors, Benchtop Bioreactors, Bubble Column Bioreactors), Usage (Full-scale Production, Lab-Scale Production, Pilot-scale Production), Control Type, Material, Scale, Usability, End User - Global Forecast 2023-2030
The Bioreactors Market is projected to reach USD 6.15 billion by 2030 from USD 2.99 billion in 2022, at a CAGR of 9.44% during the forecast period.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Bioreactors Market.
- Based on Mechanism, market is studied across Airlift Bioreactors, Benchtop Bioreactors, Bubble Column Bioreactors, Continuous Stirred Tank Bioreactors, Fluidized Bed Bioreactors, Microbial Bioreactors, Multi-Parallel Bioreactors, Packed Bed Bioreactors, and Photo-Bioreactors. The Continuous Stirred Tank Bioreactors commanded largest market share of 24.42% in 2022, followed by Microbial Bioreactors.
- Based on Usage, market is studied across Full-scale Production, Lab-Scale Production, and Pilot-scale Production. The Full-scale Production commanded largest market share of 42.63% in 2022, followed by Lab-Scale Production.
- Based on Control Type, market is studied across Automated and Manual. The Manual commanded largest market share of 78.68% in 2022, followed by Automated.
- Based on Material, market is studied across Glass and Stainless Steel. The Stainless Steel commanded largest market share of 46.68% in 2022, followed by Glass.
- Based on Scale, market is studied across 1500L-4000L, 200L-1500L, 20L-200L, 5L-20L, and Above 4000L. The 1500L-4000L commanded largest market share of 29.55% in 2022, followed by 20L-200L.
- Based on Usability, market is studied across Reusable and Single-use. The Reusable commanded largest market share of 88.88% in 2022, followed by Single-use.
- Based on End User, market is studied across Biopharmaceutical Companies & Manufacturers, Contract Manufacturing Organizations & Contract Research Organizations, Landfills & Waste Treatment Plants, and R&D Departments & Institutes. The Biopharmaceutical Companies & Manufacturers commanded largest market share of 40.43% in 2022, followed by R&D Departments & Institutes.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 45.13% in 2022, followed by Asia-Pacific.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Bioreactors Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Bioreactors Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Bioreactors Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek LLC, ABEC, Inc., Adolf Kühner AG, BBI-biotech GmbH, Belach Bioteknik, Bioengineering AG, Bionet Servicios Técnicos, SL, Broadley-James Corporation, Cell Culture Company, LLC, Cellexus Limited, CerCell A/S, Cesco Bioengineering Co., Ltd., Danaher Corporation, Distek, Inc., Electrolab Biotech Limited, Eppendorf SE, FiberCell Systems Inc., G&G Technologies, Inc., GEA Group AG, Getinge AB, IKA-Werke GmbH & CO. KG, Infors AG, Lonza Group Ltd., Merck KGaA, PBS Biotech, Inc., Pierre Guérin SA, Praj Industries Limited, Sartorius AG, Shanghai LePure Biotech Co., Ltd., Solaris Biotechnolgy Srl by Donaldson Company, Inc., Solida Biotech GmBH, Terumo Corporation, Thermo Fisher Scientific Inc., WuXi Biologics (Cayman) Inc., and ZETA GmbH.
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Bioreactors Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Bioreactors Market?
- What is the competitive strategic window for identifying opportunities in the Bioreactors Market?
- What are the latest technology trends and regulatory frameworks in the Bioreactors Market?
- What is the market share of the leading vendors in the Bioreactors Market?
- Which modes and strategic moves are suitable for entering the Bioreactors Market?
Please Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Bioreactors Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rapid growth of biopharmaceuticals and biologics industries
- 5.1.1.2. Adoption of single-use bioreactors (subs) and hybrid bioreactors
- 5.1.2. Restraints
- 5.1.2.1. Maintenance issues and high power consumption issues with bioreactors
- 5.1.3. Opportunities
- 5.1.3.1. Continuous technological advancements in the development of novel bioreactors
- 5.1.3.2. High potential of bioreactors in the wastewater treatment process
- 5.1.4. Challenges
- 5.1.4.1. Safety and environmental concerns associated with the use of bioreactors
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.3.1. Emphasis on R&D activities for advanced bioreactors with the support of established production facilities in the Americas
- 5.3.2. Supportive government initiatives and enhanced technology adoption in drug manufacturing
- 5.3.3. Vigorous biopharmaceutical research activities and well-established players in the region
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Bioreactors Market, by Mechanism
- 6.1. Introduction
- 6.2. Airlift Bioreactors
- 6.3. Benchtop Bioreactors
- 6.4. Bubble Column Bioreactors
- 6.5. Continuous Stirred Tank Bioreactors
- 6.6. Fluidized Bed Bioreactors
- 6.7. Microbial Bioreactors
- 6.8. Multi-Parallel Bioreactors
- 6.9. Packed Bed Bioreactors
- 6.10. Photo-Bioreactors
- 7. Bioreactors Market, by Usage
- 7.1. Introduction
- 7.2. Full-scale Production
- 7.3. Lab-Scale Production
- 7.4. Pilot-scale Production
- 8. Bioreactors Market, by Control Type
- 8.1. Introduction
- 8.2. Automated
- 8.3. Manual
- 9. Bioreactors Market, by Material
- 9.1. Introduction
- 9.2. Glass
- 9.3. Stainless Steel
- 10. Bioreactors Market, by Scale
- 10.1. Introduction
- 10.2. 1500L-4000L
- 10.3. 200L-1500L
- 10.4. 20L-200L
- 10.5. 5L-20L
- 10.6. Above 4000L
- 11. Bioreactors Market, by Usability
- 11.1. Introduction
- 11.2. Reusable
- 11.3. Single-use
- 12. Bioreactors Market, by End User
- 12.1. Introduction
- 12.2. Biopharmaceutical Companies & Manufacturers
- 12.3. Contract Manufacturing Organizations & Contract Research Organizations
- 12.4. Landfills & Waste Treatment Plants
- 12.5. R&D Departments & Institutes
- 13. Americas Bioreactors Market
- 13.1. Introduction
- 13.2. Argentina
- 13.3. Brazil
- 13.4. Canada
- 13.5. Mexico
- 13.6. United States
- 14. Asia-Pacific Bioreactors Market
- 14.1. Introduction
- 14.2. Australia
- 14.3. China
- 14.4. India
- 14.5. Indonesia
- 14.6. Japan
- 14.7. Malaysia
- 14.8. Philippines
- 14.9. Singapore
- 14.10. South Korea
- 14.11. Taiwan
- 14.12. Thailand
- 14.13. Vietnam
- 15. Europe, Middle East & Africa Bioreactors Market
- 15.1. Introduction
- 15.2. Denmark
- 15.3. Egypt
- 15.4. Finland
- 15.5. France
- 15.6. Germany
- 15.7. Israel
- 15.8. Italy
- 15.9. Netherlands
- 15.10. Nigeria
- 15.11. Norway
- 15.12. Poland
- 15.13. Qatar
- 15.14. Russia
- 15.15. Saudi Arabia
- 15.16. South Africa
- 15.17. Spain
- 15.18. Sweden
- 15.19. Switzerland
- 15.20. Turkey
- 15.21. United Arab Emirates
- 15.22. United Kingdom
- 16. Competitive Landscape
- 16.1. FPNV Positioning Matrix
- 16.2. Market Share Analysis, By Key Player
- 16.3. Competitive Scenario Analysis, By Key Player
- 16.3.1. Merger & Acquisition
- 16.3.1.1. Merger of Cytiva and Pall’s Life Sciences Business Now Complete
- 16.3.1.2. Merck Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition
- 16.3.2. Agreement, Collaboration, & Partnership
- 16.3.2.1. Sartorius Bioreactors Integrate Emerson Technology to Speed New Therapies to Market
- 16.3.2.2. PBS Biotech and denovoMATRIX Join Forces to Boost Manufacturing Processes for Cell & Gene Therapies
- 16.3.2.3. Lonza and Adva Biotechnology Ltd. Agree to Expand Availability and Use of Automated Bioreactors with License to Lonza’s Patents
- 16.3.2.4. Solaris Biotech and Wildtype Announce Agreement for Large-scale Bioreactors for Cultivated Seafood Production
- 16.3.2.5. STEMCELL Technologies and PBS Biotech Partner to Enable Robust Scale Up of Human Pluripotent Stem Cell 3D Cultures
- 16.3.3. Investment & Funding
- 16.3.3.1. Novo Holdings co-leads Series C financing in LePure Biotech
- 16.3.3.2. PBS Biotech Raises USD 22 million to Expand Single-Use Manufacturing Products and Services for Cell Therapy Clients
- 16.3.3.3. Stämm Biotech Raises USD 17 Million To Develop Desktop 3D Printed Bioreactor
- 17. Competitive Portfolio
- 17.1. Key Company Profiles
- 17.1.1. 3D Biotek LLC
- 17.1.2. ABEC, Inc.
- 17.1.3. Adolf Kühner AG
- 17.1.4. BBI-biotech GmbH
- 17.1.5. Belach Bioteknik
- 17.1.6. Bioengineering AG
- 17.1.7. Bionet Servicios Técnicos, SL
- 17.1.8. Broadley-James Corporation
- 17.1.9. Cell Culture Company, LLC
- 17.1.10. Cellexus Limited
- 17.1.11. CerCell A/S
- 17.1.12. Cesco Bioengineering Co., Ltd.
- 17.1.13. Danaher Corporation
- 17.1.14. Distek, Inc.
- 17.1.15. Electrolab Biotech Limited
- 17.1.16. Eppendorf SE
- 17.1.17. FiberCell Systems Inc.
- 17.1.18. G&G Technologies, Inc.
- 17.1.19. GEA Group AG
- 17.1.20. Getinge AB
- 17.1.21. IKA-Werke GmbH & CO. KG
- 17.1.22. Infors AG
- 17.1.23. Lonza Group Ltd.
- 17.1.24. Merck KGaA
- 17.1.25. PBS Biotech, Inc.
- 17.1.26. Pierre Guérin SA
- 17.1.27. Praj Industries Limited
- 17.1.28. Sartorius AG
- 17.1.29. Shanghai LePure Biotech Co., Ltd.
- 17.1.30. Solaris Biotechnolgy Srl by Donaldson Company, Inc.
- 17.1.31. Solida Biotech GmBH
- 17.1.32. Terumo Corporation
- 17.1.33. Thermo Fisher Scientific Inc.
- 17.1.34. WuXi Biologics (Cayman) Inc.
- 17.1.35. ZETA GmbH
- 17.2. Key Product Portfolio
- 18. Appendix
- 18.1. Discussion Guide
- 18.2. License & Pricing
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook